OpenOpportunity HT942526RCRPIDA

DoW Rare Cancers Idea Development Award

Defense Health Agency Contracting Activity - DHACA · Department of Defense

At a glance

DoW Rare Cancers Idea Development Award is an open federal grant opportunity from the Defense Health Agency Contracting Activity - DHACA (Department of Defense). Applications are due November 18, 2026. Total estimated funding is $7.35M across about 15 awards. The notice is unrestricted by applicant type, subject to any clarifications in the notice. Cost sharing is not required. It is funded under Assistance Listing 12.420 (Military Medical Research and Development).

Summary assembled from the official notice's fields. The official notice governs.

Key facts

Posted: Jun 17, 2026
Close date: Nov 18, 2026
Archive date: Dec 18, 2026
Award floor: Not specified
Award ceiling: Not specified
Est. total funding: $7,350,000
Expected awards: 15
Cost sharing: Not required
Funding instrument: Grant
Opportunity category: Discretionary

Who can apply

Unrestricted (any entity type)

Based on the published notice. Review the official notice for complete eligibility requirements.

What it funds

Official synopsis as published by the agency, formatted for readability.

Summary: The fiscal year 2026 (FY26) Rare Cancers Research Program (RCRP) Idea Development Award (IDA) promotes ideas that are ready for further development and have the potential to yield high-impact findings and new avenues of investigation.

Distinctive Features:

The RCRP encourages applicants to include an exploratory aim or sub-aim to support any necessary discovery-driven research.
Preliminary data with disease-specific rationale are required. However, these data do not necessarily need to originate from studies of the proposed rare cancer type(s)/subtype(s) under study.
Research should have high potential impact on rare cancers and the patient community.

Assistance Listing

What is an ALN?

12.420Military Medical Research and DevelopmentProgram →

Reported obligations under ALN 12.420

Historical data · not a prediction

FY24

$1.48B

FY25

$1.2B

FY26

— est.

Source: SAM.gov Assistance Listing 12.420. Program-wide totals, not awards from this specific opportunity.

Agency contact (as published)

JoAnn Martin Grantor
help@eBRAP.org
301-619-2594

Quick answers

When is the deadline for “DoW Rare Cancers Idea Development Award”?

According to the official notice, applications are due November 18, 2026. Confirm the deadline and submission time on Grants.gov before applying.

Who is eligible to apply for “DoW Rare Cancers Idea Development Award”?

The notice lists eligibility as unrestricted — open to any type of entity — subject to clarifications in the notice's additional eligibility information.

How much funding is available through “DoW Rare Cancers Idea Development Award”?

Per the notice, total estimated program funding is $7,350,000 and the agency expects to make about 15 awards.

How do I apply for “DoW Rare Cancers Idea Development Award”?

Applications are submitted through the official source, not through GrantsJunction. Open the official notice on Grants.gov (opportunity HT942526RCRPIDA), and review the full announcement and application package. Organizations applying through Grants.gov generally need an active SAM.gov registration and a Grants.gov account, which can take several weeks to set up.

Matched on shared Assistance Listings, agency, categories and eligible applicant types.

Closes in 6 daysALN 12.420